WEX Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that WEX Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.66B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $2.63B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $2.55B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $2.35B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.85B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $1.56B | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | $440.05M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $459.96M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $441.81M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $381.88M | Feb 28, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.85B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.87B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $1.84B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $1.69B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.35B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $1.13B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $1.21B | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $996.76M | Mar 1, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $331.31M | Mar 1, 2018 |
| FY2017 | Sep 30, 2017 | $324.00M | Mar 1, 2018 |
| FY2017 | Jun 30, 2017 | $303.88M | Mar 1, 2018 |
| FY2017 | Mar 31, 2017 | $291.36M | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | $290.84M | Mar 1, 2018 |
| FY2017 | Sep 30, 2016 | $287.76M | Mar 1, 2018 |
| FY2017 | Jun 30, 2016 | $233.94M | Mar 1, 2018 |
| FY2017 | Mar 31, 2016 | $205.93M | Mar 1, 2018 |
| FY2016 | Dec 31, 2015 | $212.64M | Mar 6, 2017 |
| FY2016 | Sep 30, 2015 | $226.06M | Mar 6, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $304.10M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $309.60M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $266.60M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $167.20M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $135.30M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | ($283.95M) | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $156.32M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $168.30M | Mar 1, 2021 |
| FY2018 | Sep 30, 2018 | $56.64M | Mar 18, 2019 |
| FY2018 | Jun 30, 2018 | $38.42M | Mar 18, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $663.90M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $686.30M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $647.10M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $469.80M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $342.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | ($91.67M) | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | $103.86M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $118.31M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $94.74M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $68.94M | Feb 28, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $454.30M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $481.40M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $907.90M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $679.40M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | ($42.60M) | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $736.80M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $663.17M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $400.23M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $135.43M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | ($141.19M) | Mar 18, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $140.60M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $147.30M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $143.60M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $112.90M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $86.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $80.47M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $102.86M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $87.15M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $79.28M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $61.80M | Mar 18, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.40B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $13.32B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $13.88B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $11.53B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $10.31B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $8.18B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $8.30B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $6.77B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $6.69B | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $6.00B | Mar 1, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.17B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $11.83B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $12.06B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $9.88B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $8.21B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $6.15B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $6.21B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $4.97B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $5.06B | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $4.49B | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.23B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.49B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $1.82B | Feb 13, 2026 |
| FY2025 | Dec 31, 2022 | $1.65B | Feb 13, 2026 |
| FY2022 | Dec 31, 2021 | $1.84B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.90B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $1.93B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.79B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $1.62B | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | $1.50B | Mar 1, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.02B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $2.98B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $3.02B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $2.73B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $2.91B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $2.69B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $2.44B | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $1.83B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $1.88B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $1.84B | Mar 18, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.37B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $2.07B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $1.76B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $1.49B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.29B | Feb 28, 2023 |
| FY2021 | Jan 1, 2021 | $1.29B | Mar 1, 2022 |
| FY2021 | Dec 31, 2020 | $1.29B | Mar 1, 2022 |
| FY2021 | Jan 1, 2020 | $1.54B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $1.54B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $1.48B | Feb 28, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $905.80M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $595.80M | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $975.80M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $922.00M | Feb 23, 2024 |
| FY2023 | Dec 31, 2021 | $588.90M | Feb 23, 2024 |
| FY2023 | Dec 31, 2020 | $852.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2019 | $810.93M | Feb 28, 2023 |
| FY2021 | Dec 31, 2018 | $541.50M | Mar 1, 2022 |
| FY2020 | Dec 31, 2017 | $503.52M | Mar 1, 2021 |
| FY2019 | Dec 31, 2016 | $190.93M | Feb 28, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Jan 1, 2021 | $2.87B | Mar 1, 2022 |
| FY2019 | Dec 31, 2019 | $2.69B | Feb 28, 2020 |
| FY2019 | Dec 31, 2018 | $2.13B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $2.03B | Mar 18, 2019 |
| FY2015 | Dec 31, 2015 | $1.07B | Feb 26, 2016 |
| FY2015 | Dec 31, 2014 | $1.30B | Feb 26, 2016 |
| FY2014 | Dec 31, 2013 | $685.00M | Feb 26, 2015 |
| FY2013 | Dec 31, 2012 | $621.00M | Feb 27, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 6 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | (5) | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 28, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 6 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | (5) | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 28, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 34.30M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 39.00M | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | 41.90M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | 43.20M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | 44.83M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | 44.19M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | 43.32M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | 43.13M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | 43.02M | Mar 18, 2019 |
| FY2017 | Dec 31, 2016 | 42.84M | Mar 1, 2018 |